Page last updated: 2024-12-08
cyanex 272
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Cyanex 272: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 157898 |
CHEMBL ID | 1476841 |
SCHEMBL ID | 186893 |
MeSH ID | M0513964 |
Synonyms (23)
Synonym |
---|
NCGC00166110-01 |
83411-71-6 |
bis(2,4,4-trimethylpentyl)phosphinic acid |
bis(2,4,4-trimethylpentyl)-phosphinic acid |
phosphinic acid, bis(2,4,4-trimethylpentyl)- |
phosphinic acid, p,p-bis(2,4,4-trimethylpentyl)- |
einecs 280-445-7 |
ec 280-445-7 |
cyanex 272 |
FT-0689045 |
CHEMBL1476841 |
SCHEMBL186893 |
W-111573 |
AKOS024438132 |
bis(2,4,4-trimethylpentyl)phosphinicacid |
c16h35o2p |
J-016844 |
p,p-bis(2,4,4-trimethylpentyl)phosphinic acid |
DTXSID60868724 |
CS-0032791 |
mfcd28145690 |
SY113742 |
A864266 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (2)
Potency Measurements
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 5.6234 | 0.0032 | 45.4673 | 12,589.2998 | AID2517 |
vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 89.1251 | 0.3548 | 28.0659 | 89.1251 | AID504847 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 3 (27.27) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 43.75
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (43.75) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 14 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |